Norleu

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug NameNorleu
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNerve DegenerationStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHedral Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHedral Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsNerve DegenerationStroke

Other Information

ATC CodeN/A
Related LinksN/A